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Abstract 
 
WBC count and the platelet index (MPV) at the 
admission time of patients with STEMI, are the 
strong predictors for undesirable outcomes of 
patients. The objective of the present study was 
to determine the relationship between the 
hematologic indices including MPV and WBC 
count at the admission time of patients with ST 
resolution index in patients with STEMI who 
were treated by thrombolytic agents. 
 
In this prospective study, venous blood 
samples of 114 patients with STEMI were taken 
to determine PDW, MPV and WBC count at 
patients' referral time and before thrombolytic 
therapy. According to ST resolution index in 90 
minutes after thrombolytic therapy, patients 
were classified in two groups with ST resolution 
less than 50% and ST resolution of 50% or 
more. Finally, values of the laboratory indices 
above were compared between two ST-
resolution groups that this issue was carried out 
using the SPSS version 21 software. 
 
In assessing through ROC curve analysis, it was 
determined that measuring MPV is not 
  Resumen  
 
El recuento de glóbulos blancos y el índice de 
plaquetas (MPV) en el momento de la admisión 
de los pacientes con STEMI, son los factores 
predictivos fuertes para los resultados no 
deseados de los pacientes. El objetivo del 
presente estudio fue determinar la relación 
entre los índices hematológicos, incluido el 
recuento de MPV y WBC en el momento de la 
admisión de los pacientes con índice de 
resolución de ST en pacientes con STEMI que 
fueron tratados con agentes trombolíticos. 
 
En este estudio prospectivo, se tomaron 
muestras de sangre venosa de 114 pacientes con 
STEMI para determinar el recuento de PDW, 
MPV y WBC en el tiempo de referencia de los 
pacientes y antes de la terapia trombolítica. 
Según el índice de resolución de ST en 90 
minutos después de la terapia trombolítica, los 
pacientes se clasificaron en dos grupos con 
resolución de ST inferior al 50% y resolución de 
ST del 50% o más. Finalmente, los valores de 
los índices de laboratorio anteriores se 
compararon entre dos grupos de resolución de 
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considered as an accurate and effective index in 
predicting ST resolution after thrombolysis 
(Area Under Curve: 0.574). WBC count was not 
an applicable indicator for predicting ST 
resolution after thrombolysis, as well (Area 
Under Curve: 0.660). Finally, the results of 
multiple logistic regression model showed that 
the only predictor of ST resolution less than 
50% is the history of using statins so that history 
of using statin increased the probability of ST 
resolution less than 50% for 7 times (P: 0.028, 
OR: 7.306).  
 
There is not a relationship between the 
occurrence of complete ST resolution (more 
than 50%) and the values of both MPV and WBC 
indices. So, measuring these two indicators may 
not have the enough validity for predicting ST 
resolution after thrombolysis. According to our 
study, patients with history of using statins have 
a lower prevalence of complete ST resolution 
(more than 50%). 
 
Keywords: Hematologic indices, 
thrombolysis, myocardial infarction, ST segment 
 
 
 
ST que este problema se llevó a cabo utilizando 
el software SPSS versión 21. 
 
Al evaluar a través del análisis de la curva ROC, 
se determinó que la medición de MPV no se 
considera como un índice preciso y eficaz para 
predecir la resolución de ST después de la 
trombólisis (área bajo la curva: 0.574). El 
recuento de WBC tampoco fue un indicador 
aplicable para predecir la resolución de ST 
después de la trombolisis (Área bajo la curva: 
0.660). Finalmente, los resultados del modelo 
de regresión logística múltiple mostraron que el 
único predictor de resolución de ST inferior al 
50% es el historial de uso de estatinas, de modo 
que el historial de uso de estatinas aumentó la 
probabilidad de resolución de ST inferior al 50% 
en 7 veces (P: 0,028), O: 7.306). 
 
No existe una relación entre la aparición de 
una resolución completa de ST (más del 50%) y 
los valores de los índices de MPV y WBC. Por lo 
tanto, la medición de estos dos indicadores 
puede no tener la suficiente validez para 
predecir la resolución del ST después de la 
trombólisis. Según nuestro estudio, los 
pacientes con antecedentes de uso de estatinas 
tienen una prevalencia más baja de resolución 
completa de ST (más del 50%). 
 
Palabras clave: índices hematológicos, 
trombólisis, infarto de miocardio, segmento ST. 
Resumo
 
A contagem de leucócitos e o índice plaquetário (VPM) no momento da admissão de pacientes com 
IAMCSST são fortes preditores de desfechos indesejáveis dos pacientes. O objetivo do presente estudo foi 
determinar a relação entre os índices hematológicos, incluindo MPV e contagem de leucócitos no momento 
da admissão de pacientes com índice de resolução de ST em pacientes com STEMI que foram tratados por 
agentes trombolíticos. 
 
Neste estudo prospectivo, amostras de sangue venoso de 114 pacientes com IAMCST foram tomadas 
para determinar a contagem de PDW, MPV e leucócitos no momento do encaminhamento dos pacientes 
e antes da terapia trombolítica. De acordo com o índice de resolução de ST em 90 minutos após a terapia 
trombolítica, os pacientes foram classificados em dois grupos com resolução de ST menor que 50% e 
resolução de ST de 50% ou mais. Finalmente, os valores dos índices laboratoriais acima foram comparados 
entre os dois grupos de resolução ST que esta questão foi realizada usando o software SPSS versão 21. 
 
Na avaliação através da análise da curva ROC, determinou-se que a medição do VPM não é considerada 
como um índice preciso e eficaz na predição da resolução de ST após trombólise (Area Under Curve: 
0,574). A contagem de leucócitos também não foi um indicador aplicável para prever a resolução de ST 
após trombólise (Area Under Curve: 0.660). Finalmente, os resultados do modelo de regressão logística 
múltipla mostraram que o único preditor de resolução de ST inferior a 50% é a história de uso de estatinas 
para que a história de uso de estatina aumente a probabilidade de resolução de ST menor que 50% por 7 
vezes (P: 0,028 , OR: 7,306). 
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Não há relação entre a ocorrência de resolução completa do ST (mais de 50%) e os valores dos índices 
de MPV e WBC. Portanto, a medição desses dois indicadores pode não ter validade suficiente para prever 
a resolução de ST após trombólise. De acordo com nosso estudo, pacientes com história de uso de 
estatinas têm uma menor prevalência de resolução completa de ST (mais de 50%). 
 
Palavras-chave: índices hematológicos, trombólise, infarto do miocárdio, segmento ST 
 
Introduction 
 
In the recent decade, several observations led 
to the confirmation of the benefits of evaluation 
and monitoring of ST resolution indices after 
occurrence of STEMI. For the first time, 
Schroder et al found that ST resolution predicts 
the risk of mortality and congestive heart failure 
in patients treated by fibrinolytic therapy, 
effectively (Schröder et al., 1994; Schröder et al., 
1995). Another studies confirmed the 
relationship between the degree of ST resolution 
and mortality. In another study by Ito et al, it was 
determined that epicardial normal blood store is 
not sufficient for evaluation and providing 
adequate myocardial reperfusion (Ito et al., 
1992; Ito et al., 1996). In fact, new reperfusion 
regimens were developed to improve the 
limitations of two fibrinolytic and anticoagulant 
therapies (Ohman et al., 1997;  Antman et al., 
2000) and these therapies may be particularly 
useful in providing coronary micro-circulation 
(SPEED, 2000). 
 
ST resolution is currently evaluated in many 
clinical trials and managing patients. Primary 
studies on ST resolution showed this fact that 
patients with sharper ST resolution had a lower 
level of infarction compared to the patients with 
stable ST-elevation (Neumann et al., 1998). 
Further studies confirmed that there is a 
significant relationship between ST resolution 
and clinical outcomes of the patients. In a large 
study on 7426 patients, it became clear that two 
third of patients with ST resolution more than 
50% were four hours after thrombolysis therapy 
so that these patients had a thirty-day mortality 
rate of 3.5% against the mortality of 7.4% in 
patients with ST resolution less than 50% (de 
Lemos et al., 2000). On the other hand, Schorder 
et al developed a new three-part definition for 
the total resolution of 180 minutes ST elevation 
after thrombolysis which was included complete 
resolution (more than 70%), relative (between 
30 to 70%) and without resolution (less than 
30%). In trials on fibrinolytic treatments, a strong 
relationship between ST resolution and the 
reduction in the mortality of patients was 
observed (Schröder et al., 1999). In newer 
studies, it was determined that evaluation of ST 
resolution even in 3 to 4 first hours after the 
beginning of fibrinolytic therapy, can determine 
the risk of death as well as heart failure in patients 
(Purcell, Newall & Farrer, 1997; Carlsson et al., 
1999; de Lemos et al., 2000, 101(3); de Lemos 
et al., 2000, 140(3)). In addition, it has been 
determined that patients with complete ST 
resolution within 60 minutes had a much lower 
risk for these two consequences than those 
patients with ST resolution within 90 minutes 
(Matetzky et al., 1998). Due to the slower 
beginning of fibrinolytic streptokinase activation, 
90 minutes is a very limited time for the creation 
of ST resolution and therefore 180 minutes is 
considered as an acceptable time to assess 
streptokinase activity in the creation of 
reperfusion (Schröder et al., 1999). In addition, 
along with predicting mortality, the degree of ST 
resolution is capable to predict the left 
ventricular dysfunction and heart failure. So that 
the more complete ST resolution is related to 
the more limited size of infarction and more 
improvement of left ventricular function (Saran 
et al., 1990; Matetzky et al., 1999; Shah et al., 
2000). Similar to mortality, the risk of heart 
failure in a wider and faster ST resolution cases, 
has been associated with a reduction in the risk 
of heart failure (Andrews et al., 2000).  
 
The special importance of predicting ability of 
ST resolution is mainly related to its relationship 
with epicardial blood flow. In a study, it was 
determined that under thrombolysis and 90 
minutes after it, patients with ST resolution less 
than 70% had 10-fold higher mortality than the 
patients with ST resolution more than 70% 
(van’t Hof et al., 1997). Interestingly, there was 
no difference between two groups with TIMI II 
and TIMI III and ST resolution in terms of being 
complete or relative. It was observed through 
monitoring that patients with faster recovery of 
stable ST had faster improvement and 
restoration of infarction that this issue has been 
independent from TIMI degree. In another study, 
ST resolution and not the grade of TIMI was the 
predictor of mortality and heart failure (Andrews 
et al., 2000; van’t Hof et al., 1997). 
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Other evidences showed the prognostic value 
of ST resolution derived from the experiences 
related to primary PCI in patients with STEMI. 
After the successful primary PCI in patients with 
STEMI, continuous ST elevation had been 
associated with weaker recovery of left 
ventricular function and therefore increased 
mortality (Andrews et al., 2000; van’t Hof et al., 
1997; Somitsu et al., 1997). Risk of death and 
heart failure in patients with increased level of ST 
after PCI had been increased because of 
increased extent of infarction (Claeys et al., 
1999; Dissmann et al., 1993; Kondo et al., 1993). 
In addition, it is proposed that ST resolution is 
associated with providing tissue reperfusion. By 
creating the ST resolution at 90 minutes after 
fibrinolysis, reperfusion has been completely 
developed in both epicardial and microvascular 
levels that leads to an excellent outcome in the 
patient. Another important point in this regard 
was the companying role of other risk factors in 
patients with STEMI including age, high weight, 
infarction, the onset of treatment, evidences of 
brain involvement, diabetes and hypertension 
with the history of coronary heart disease (Miida 
et al., 1994). Interestingly, in both groups of 
patients with and without any of mentioned risk 
factors, the presence of ST resolution has still 
been a predictor of lower mortality in these 
patients (Morrow et al., 2000). Recently, it has 
determined that some factors such as previous 
cardiac biomarker level before fibrinolytic 
therapy can be stronger predictors of mortality 
alongside the lack of ST resolution (Ohman et al., 
1996; Stubbs et al., 1996; Ohman et al., 1999). It 
has also been shown that the evaluation of 
myoglobin immediately before fibrinolysis along 
with evaluation of ST resolution 60 to 90 minutes 
before the therapy can provide more complete 
information on predicting undesirable outcomes 
in patients that increased myoglobin associated 
with the lack of 90-minutes ST resolution 
increase the risk of mortality up to 25 times 
(Stubbs et al., 1996). 
 
Recently, the role of other factors and 
biomarkers especially hematologic factors 
related to ST resolution has been evaluated. As 
we know, platelets play a basic role in the 
pathogenesis of atherosclerosis and the spread of 
thrombotic coronary events. Platelets are mainly 
produced in stressful conditions such as acute 
coronary syndrome that platelets will be the high 
stimulator of B2 thromboxan production (van 
der Loo & Martin, 1999). The Mean Platelet 
Volume (MPV) and Platelet Distribution Width 
(PDW) are considered as the risk factors of MI 
occurrence and stroke and finally mortality in 
patients with STEMI (Huczek et al., 2005; 
Massberg, Schulz & Gawaz, 2003; Sabatine et al., 
2002). Also, leukocytosis plays an important role 
in the occurrence and progression of 
atherosclerosis and acute coronary syndrome 
(Vagdatli et al., 2010). But, what has been still 
unclear for the researchers is the role these 
hematologic indices in evaluating the adequacy of 
reperfusion following the thrombolytic therapy 
especially in relation to or in association with 
occurrence of ST resolution. 
 
Acute myocardial infarction is a clinical 
syndrome in which evidences of myocardial 
ischemia is associated with symptoms of 
myocardial necrosis in the electrocardiogram, 
biochemical tests and imaging modalities. One of 
the types of acute myocardial infarction is 
determined by ST segment elevation in the 
electrocardiogram and necrosis of all walls 
(Khademvatani et al., 2016; Yalcin et al., 2015; 
Khademvatan et al., 2014; Heris et al., 2014). 
Using the rapid, accurate and non-invasive 
methods to evaluate the efficacy of reperfusion 
and thrombolysis therapies in patients with acute 
myocardial infarction is an essential issue. In the 
recent decade, many observations have been 
made about the efficacy of monitoring of ST 
segment changes as a simple and accessible 
method in patients with acute myocardial 
infarction treated by reperfusion and ST 
resolution was significantly considered in this 
regard (Darabad et al., 2014; Poorrafsanjani & 
Darabad, 2014). For the first time in 1994, it was 
determined that this index can even predict the 
risk of death and occurrence of congestive heart 
failure in patients under fibrinolytic therapy. In 
this regard, further studies showed that there is 
a strong significant relationship between the 
degree and severity of ST resolution and the risk 
of mortality following the above mentioned 
therapies and therefore this indicator was really 
considered as a prognostic measure in patients 
treated by reperfusion (thrombolytic and also 
interventional).  
 
Both inflammatory and coagulative 
hematologic indicators play essential roles in the 
occurrence and pathogenesis of acute coronary 
syndrome. It has been approved in studies that 
there is a significant relationship between the 
platelet size considered as mean platelet volume 
and the platelet activity. On the other hand, the 
platelets with higher mean platelet volume 
(MPV) are more active in terms of metabolic and 
enzymatic ranges and therefore have more 
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thrombotic effects. In addition, an increase in 
MPV level has been an independent risk factor 
for the clinical reverse-outcomes in patients with 
acute myocardial infarction. However, the 
relationship between MPV and myocardial 
reperfusion disorders is not still fully understood.  
 
On the other hand, the role of inflammation has 
been fully known as a potential risk factor for 
developing cardiovascular events. Leukocyte 
response observed during STEMI indicates the 
role and is considered as an essential component 
of systemic inflammatory response to myocardial 
injury. WBC count in time of admission of the 
patients is a strong predictor for increasing 
mortality and morbidity of patients with STEMI. 
In this regard, it is found that there is a 
relationship between the increase in WBC count 
and the reduction of epicardial and myocardial 
blood flow in patients with STEMI.  
 
Along with the above studies, the present study 
was conducted aimed to evaluate the 
relationship between the hematologic indices 
including MPV and WBC count in the time of 
admission and ST resolution index in patients 
with STEMI treated by thrombolytics. This study 
was carried out in Azerbayjan Province for the 
first time, but its similar studies have been done 
in Tabriz and Yazd which are mentioned in 
scientific literature section. 
 
Method 
 
In this prospective case-control study, basic 
details of the patients such as demographic 
information, height, weight and body mass index 
(BMI), history of heart disease risk factors such 
as familial history of heart diseases, hypertension, 
hyperlipidemia, diabetes mellitus and smoking, 
history of drug use especially using heart drugs, 
previous history of cardiovascular interventions, 
history of myocardial infarction, history of heart 
failure, previous history of cerebrovascular 
events, history of renal failure, history of 
peripheral arterial hypertension and history of 
chronic obstructive pulmonary disease were 
extracted from the patients' records data and 
registered in the special questionnaire of the 
project. At the patients' referral time and prior to 
thrombotic therapy, venous blood samples were 
taken to measure PDW, MPV indices and WBC 
count and data were registered in the patients' 
records. Patients were treated by thrombolysis 
in an equal condition (including streptokinase 1.5 
million units in 20-30 minutes) with a German-
made Streptase drug. ST elevation was measured 
from the J point in ST segment as well as in two 
electrocardiograms during the initial 
hospitalization and 90 minutes after thrombotic 
therapy. According to ST resolution index, 90 
minutes after thrombotic therapy, patients were 
classified in two groups of ST resolution less than 
50% and ST resolution of 50% or more. Finally, 
values of the above laboratory indices were 
compared between two ST resolution groups.  
 
Criteria to enter the study: 
 
The presence of STEMI diagnostic criteria are 
based on clinical symptoms (continues typical 
chest angina for more than 30 minutes), ECG 
changes (ST segment elevation more than 2 mm 
in pre-cordial lids and more than 1 mm in limb 
lids in more than two adjacent lids) and increased 
cardiac enzymes, 2) receiving thrombolytic 
treatments, 3) the first occurrence of myocardial 
infarction. 
 
Criteria to exit the study: 
 
1)Delay to visit for more than 6 hours from the 
onset of symptoms, 2) presence of LBBB, 3) 
presence of ventricular tachycardia arrhythmias 
and ventricular fibrillation, 4) rhythm resulted 
from the pacemaker, 5) incomplete or non-
judgmental electrocardiogram, 6) cases of 
thrombolytic inhibition including fibrinolytic 
therapy within the recent 24 hours, anti-
coagulant therapy, having congenital 
hemorrhagic factors, renal insufficiency, history 
of malignancy, history of chronic inflammatory 
disease and or active infection, intra-ventricular 
conduction abnormalities, aortic dissection, 
systolic hypertension higher than 180 mmHg, 
history of trauma to the head or any surgery 
during the recent 3 months, history of 
thrombocytopenia, presence of cardiogenic 
shock, 7) presence of concurrent internal or 
infectious diseases effective on the laboratory 
parameters under the study, 8) patients who 
already have aspirin and clopidogrel. 
 
Finally, SPSS version 21 software was used to 
analyze the data of above study. 
 
Results  
 
A total of 114 patients were evaluated. In terms 
of ST resolution, 43 cases (37.7%) and 70 cases 
(61.3%) had resolution of less than 50% and 
resolution of more than 50%, respectively. In the 
comparison of basic details between the patients 
with the resolutions less than 50% and more 
  
     Encuentre este artículo en http://www.udla.edu.co/rev istas/ index.php/amazonia - investiga         ISSN 2322- 6307 
144 
than 50%, we found that in terms of sexual 
distribution, frequency of men in people with 
resolution less than 50% was 69.8% and in 
people with resolution higher than 50% was 
90.1% that the difference was statistically 
significant (P: 0.006). in terms of the mean age, 
mean ages in the groups of resolution less than 
50% and resolution higher than 50% were  
62.07±12.96 years and 56.32±9.29 years old 
that the difference was statistically significant, as 
well (P: 0.007). in terms of frequency of the risk 
factors of heart diseases, prevalence of diabetes 
were 23.3% and 9.9% in the groups with 
resolutions less than 50% and more than 50%, 
respectively that was significantly higher in the 
first group (P: 0.052). The prevalence of 
hypertension in the groups with the resolutions 
less and more than 50% were 44.2% and 18.3% 
respectively and it was significantly higher in the 
first group (P" 0.003). in terms of the smoking 
history, the prevalence of smoking in the groups 
with resolutions less and more than 50% were 
37.2 and 35.2%, respectively that no difference 
was seen in those groups (P: 0.829). In terms of 
using opium in the groups with resolutions less 
and more than 50%, they were 11.6% and 8.5% 
respectively and without a difference between 
those groups, as well (P: 0.745). In terms of 
hyperlipidemia, the prevalence of this 
complication in the groups with resolutions less 
and more than 50% were 11.6% and 7%, 
respectively and without a difference between 
those groups, as well (P: 0.402).  
 
Prevalence of MI in the groups with resolutions 
less and more than 50% were 14% and 4.2%, 
respectively and without a difference between 
those groups, as well (P: 0.07). Prevalence of 
pulmonary diseases in the groups with 
resolutions less and more than 50% were 4.7% 
and 5.6.2%, respectively and without a 
difference between those groups, as well (P: 
0.999). In terms of familial cardiovascular 
diseases, this history in the groups with 
resolutions less and more than 50% were 4.7% 
and 12.7%, respectively and without a difference 
between those groups, as well (P: 0.209). Also, 
in terms of prevalence of peripheral vascular 
disease, this prevalnce in the groups with 
resolutions less and more than 50% were 4.7% 
and 0%, respectively and without a difference 
between those groups, as well (P: 0.14).  
 
Table 1- Basic details of patients with ST resolution of less and more than 50% 
 
Details  
Resolution less than 
50% 
Resolution more 
than 50% 
p-value 
Frequency of men 69.8% 90.1% 0.006 
Mean age (years old) 62.07±12.96 56.32±9.29 0.007 
Prevalence of diabetes 23.3% 9.9% 0.052 
Prevalence of hypertension 44.2% 18.3% 0.003 
Prevalence of smoking 37.2% 35.2% 0.829 
Prevalence of using opium 11.6% 8.5% 0.745 
Prevalence of hyperlipidemia 11.6% 7.0% 0.402 
Prevalence of pulmonary diseases 4.7% 5.6% 0.999 
History of cardiac diseases 4.7% 12.7% 0.209 
History of peripheral vascular diseases 4.7% 0% 0.140 
Using of statins 16.3% 2.8% 0.026 
Using β blockers 0 4.2% 0.289 
Using ACE inhibitors 18.6% 9.9% 0.181 
Using Ca blockers 0 8.5% 0.082 
Using anti-diabetic drugs 14.0% 5.6% 0.174 
Frequency of using diuretic drugs 0 1.4% 0.999 
Mean of MPV 9.42±0.77 9.59±1.00 0.377 
Mean of WBC count 10027.91±2433.04 10520.00±2800.03 0.343 
 
In terms of using the cardiovascular drugs, the 
prevalence of using statins in the groups of 
resolution less and more than 50% were 16.3% 
and 2.8%, respectively that in the first group was 
significantly higher than the second group 
(P:0.026). Frequency of beta blockers in the 
groups of resolution less and more than 50% 
were 0% and 4.2%, respectively that there was 
no difference between both groups (P: 0.289). 
Frequency of using ACE inhibitors in the groups 
of resolution less and more than 50% were 
18.6% and 9.9%, respectively and without any 
difference between two groups (P: 0.181). 
Similarly, using the Ca blockers in the groups of 
resolution less and more than 50% were 
evaluated as 0% and 8.5%, respectively and with 
no difference between two groups, as well (P: 
0.082). Frequency of using anti-diabetic drugs in 
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the groups of resolution less and more than 50% 
were 14% and 5.6%, respectively that the 
difference between the groups was not 
significant (P: 0.174). Also, frequency of using 
diuretic drugs in the groups of resolution less and 
more than 50% were 0% and 1.4%, 
respectively and without any difference between 
two groups, again (P: 0.999). (Table 1) 
 
Mean of MPV in patients with resolution less 
than 50% was 9.42±0.77 as well as 9.59±1.00 
in the patients with resolution more than 50% 
that the difference between two groups was not 
significant (P: 0.377). Mean of WBC count in 
patients with resolution less and more than 50% 
were 1027.91±2433.04 and 
10520.00±2800.03, respectively and the 
difference between two groups was not 
significant (P: 0.343). (Table 1) 
 
In the evaluation with multiple logistic 
regression, the only predictor of ST resolution 
less than 50% was using statins so than the 
history of using statin increased the probability of 
ST resolution less than 50% for about 7 times (P: 
0.028, OR: 7.306). 
 
Table 2- Logistic regression model in determining the factors related to resolution less than 50% 
 
Index Beta coefficient SE p-value OR 
Gender -0.584 0.630 0.354 0.558 
Age -0.032 0.022 0.150 0.969 
diabetes 0.299 0.651 0.646 1.349 
Hypertension 0.837 0.517 0.105 2.310 
Using statin 1.989 0.902 0.028 7.306 
 
In the evaluation by ROC curve analysis, it was found that determination of MPV is not considered as an 
accurate and efficient indicator in predicting ST resolution after thrombolysis (area under curve: 0.574). 
Determining WBC count was not an applicable indicator for predicting ST resolution after thrombolysis, 
as well (area under curve: 0.660) (charts 1, 2) 
 
Chart 1- AUC-ROC for MPV to differentiate the resolutions less and more than 50% 
 
Chart 2- AUC-ROC for MPV to differentiate the resolutions less and more than 50% 
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Discussion and Conclusion 
 
First of all, the purpose of this study was to 
evaluate the difference between MPV and WBC 
indices in two groups of patients with ST 
resolution less and more than 50% after 
thrombolysis. In fact, the objective was to find if 
these two measures have an acceptable value to 
differentiate ST resolutions less and more than 
50% after thrombolysis or not or on the other 
hand, whether a cut-off point is obtained that 
considering that cut-off point for two MPV and 
WBC indicators, ST resolution less and more 
than 50% can be differentiated with acceptable 
sensitivity and specificity or not. Despite the 
observed numerical difference in two MPV and 
WBC indicators between two groups of ST 
resolution less and more than 50%, this 
difference was not statistically significant 
according to this study. Also, in the evaluation of 
area under ROC curve (AUC-ROC), it was 
shown that none of these indicators are valuable 
enough to differentiate ST resolutions less and 
more than 50% and therefore a cut-off point 
with acceptable sensitivity and specificity for such 
this differentiation ability cannot be determined. 
Unlike some conducted studies, our study was 
not able to determine the relationship between 
MPV as well as WBC with ST resolution. In 
Ghaffari et al study, patients with MPV higher 
than 8.2 fl had lower ST resolution and fewer 
acute heart failures. In the evaluation with 
regression model, MPV was the predictor for ST 
resolution as well as MACE occurrence 
(Khademvatani et al., 2016) that was completely 
contrary to our study. In the study of Kirbas et al, 
MPV value in patients with ST resolution less 
than 50% was lower than it in patients with ST 
resolution more than 50% and based on ROC 
curve analysis, the cut-off point of 9.3 fl for MPV 
was the strong predictor for predicting ST 
resolution with the sensitivity of 66.7% and 
77.9% (Kırbaş et al., 2014) that was not contrary 
to our study, as well. In Varasteh et al study, 
patients with ST resolution less than 70% had 
higher values of MPV, PDW and WBC count. 
The best cut-off point of MPV for predicting ST 
resolution less than 70% was 10.05 fl with the 
sensitivity and specificity of 71.8% and 80.9%, 
respectively. Also, the best cut-off point of WBC 
count for predicting ST resolution less than 70% 
was 12.65 per thousand with the sensitivity and 
specificity of 42.9% and 82.7%, respectively 
(Varasteh-Ravan et al., 2013). Of course, the 
studies conducted about the relationship 
between ST resolution and values of the 
laboratory indicators are very few. In general, it 
seems that the disapproval reason of the 
relationship between ST resolution and values of 
MPV and WBC indicators can be the following 
items. First, determination of cut-off point for ST 
resolution has been different in various studies so 
that in some studies the cross section of 50% 
was considered and in the others, 70% was 
considered that can be very effective in the 
significance of differences between the groups. 
Second, the time range was mainly 1 to 4 hours 
in order to determine resolution after 
thrombolysis which affects on the laboratory 
indices and occurrence of a complete resolution 
(which was less than 6 hours in our study). Third, 
type of thrombolysis therapy as well as its 
associated treatments may be effective on the 
occurrence of complete resolution after 
thrombolysis. It is important to mention that in 
the above studies, the history of using aspirin and 
clopidogrel was not included in the exclusion 
criteria while in our study, patients with history 
of using these drugs excluded from the study and 
this point can be effective in the results of the 
study. Also, type of using technique and its 
accuracy estimating the laboratory indices will be 
an important and effective factor in determining 
the relationship among the indices and 
occurrence of a complete resolution. So, with 
the presence of possible contingency indicators 
mentioned above, it is not possible to find a 
significant relationship between two MPV and 
WBC laboratory indices and the occurrence of a 
complete resolution. 
 
In this regard, history of using statin was only 
related to resolution occurrence among all basic 
indices of patients and multiple logistic 
regression. The obtained result was the reverse 
finding of Varasteh et al in which among all 
patients' indices, only the history of using statins 
was different between two groups of with and 
without resolution was different, but the group 
with the use of statin ST resolution more than 
50% (Varasteh-Ravan et al., 2013). Of course, 
the cause of this relationship was not evaluated 
in their study, as well. In some studies, using 
statins was associated with the improvement of 
ST resolution (Kim et al., 2010). Although, in 
some other studies, there was not a significant 
relationship between the history of using statins 
and occurrence of improving complete ST 
resolution (Woo et al., 2011). Maybe, the 
relationship between using statin and ST 
resolution is due to the effect of drug on the 
inflammatory indices and predicting the 
occurrence and development of ischemia in 
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myocardial tissue, however it requires further 
studies and evaluation. 
 
Finally, t can be said that in our study, there is 
no relationship between the occurrence of 
complete ST resolution (more than 50%) and 
the values of both MPV and WBC indicators. 
Therefore, there are not enough evidences that 
show the assessment of these indicators have the 
enough value for predicting ST resolution after 
thrombolysis based on this study. According to 
our study, patients with history of using statins 
have lower prevalence of complete ST resolution 
(more than 50%).  
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